To evaluate the reliability of quantitative magnetic resonance imaging (MRI) in the diagnosis and follow-up of patients with NASH. Methods or Background From March to September 2021 twenty patients who met diagnostic criteria for NASH and twenty healthy volunteers were enrolled and underwent quantitative 1.5T MRI examination of the liver. Acquisition protocol comprised magnetic resonance elastography (MRE) and proton density fat fraction (PDFF). Image post-processing was performed with a dedicated workstation. Quantitative image analysis was performed by a radiologist with 15 years of experience in abdominal MRI; liver stiffness (kPa) and grade of steatosis (%) were collected. Statistical analysis was performed using a dedicated software ...
BackgroundMagnetic resonance imaging-derived measures of liver fat and volume are emerging as accura...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease...
To evaluate the reliability of quantitative magnetic resonance imaging (MRI) in the diagnosis and fo...
Background & aimsNon-invasive tools for monitoring treatment response and disease progression in...
Background & aimsNon-invasive tools for monitoring treatment response and disease progression in...
Background & aimsNon-invasive tools for monitoring treatment response and disease progression in...
BACKGROUND & AIMS: Non-invasive tools for monitoring treatment response and disease progression in n...
Non-alcoholic fatty liver disease (NAFLD) represents one of the most common causes of chronic liver ...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is rapidly increasing worldwide. It is subdivid...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is rapidly increasing worldwide. It is subdivid...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
BackgroundMagnetic resonance imaging-derived measures of liver fat and volume are emerging as accura...
BackgroundMagnetic resonance imaging-derived measures of liver fat and volume are emerging as accura...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease...
To evaluate the reliability of quantitative magnetic resonance imaging (MRI) in the diagnosis and fo...
Background & aimsNon-invasive tools for monitoring treatment response and disease progression in...
Background & aimsNon-invasive tools for monitoring treatment response and disease progression in...
Background & aimsNon-invasive tools for monitoring treatment response and disease progression in...
BACKGROUND & AIMS: Non-invasive tools for monitoring treatment response and disease progression in n...
Non-alcoholic fatty liver disease (NAFLD) represents one of the most common causes of chronic liver ...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is rapidly increasing worldwide. It is subdivid...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is rapidly increasing worldwide. It is subdivid...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
BackgroundMagnetic resonance imaging-derived measures of liver fat and volume are emerging as accura...
BackgroundMagnetic resonance imaging-derived measures of liver fat and volume are emerging as accura...
International audienceNon-alcoholic steatohepatitis (NASH) is characterized at histology by steatosi...
Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease...